Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers April 19, 2019
Pharmacy Choice - Pharmaceutical News - Ninth Annual Research Breakfast Brings Cancer Experts Together to Discuss Current State of Clinical Trials - April 19, 2019

Pharmacy News Article

 10/11/18 - Ninth Annual Research Breakfast Brings Cancer Experts Together to Discuss Current State of Clinical Trials

WASHINGTON, Oct. 9 The American Cancer Society Cancer Action Network issued the following news release:

Nearly 150 people attended the American Cancer Society Cancer Action Network's (ACS CAN) ninth annual Cancer Research Breakfast earlier today at the North Carolina Museum of History. The event provided a forum for leaders in industry, advocacy, academia, and public policy to discuss the current state of therapeutic clinical trials and the need to focus on the barriers to patient enrollment and efforts needed to overcome them.

North Carolina's three NCI-Designated Cancer Centers, UNC Lineberger Comprehensive Cancer Center, Duke Cancer Institute, and Wake Forest Baptist Medical Comprehensive Cancer Centers served as the honorary hosts for the Research Breakfast.

"Today's breakfast is just one of five clinical trial forums being held across the country that are focusing on ACS CAN's Report: Barriers to Patient Enrollment in Therapeutic Clinical Trials for Cancer," said Christine Weason, ACS CAN North Carolina government relations director. "We convened key thought leaders and subject matter experts from the cancer community to gain foundational insight to the barriers identified in the report and to explore potential opportunities and promising practices that may alleviate the barriers patients confront in enrolling and participating in clinical trials."

Hoping to improve patient enrollment, ACS CAN and 14 other organizations from all sectors of the cancer research community including patient advocacy groups, provider groups, cancer institutions, and the drug research and development industry, developed a set of consensus recommendations detailed in the report. Examples include making the discussion of specific trial options a more regular part of the doctor-patient treatment decision, increasing funding for trial-support personnel to help patients understand, enroll and manage their trial, and helping patients with added costs that occasionally result from trial participation such as travel, parking, and housing.

While many initiatives have been launched to tackle barriers to cancer clinical trial enrollment, they tend to focus on a subset of the overall barriers. For example, patient education and decision making are often the focus of efforts to increase participation, yet other structural and clinical factors like the lack of locally available clinical trials matching a patient's characteristics or lack of interest on the part of providers to recommend clinical trials as an option for up to 75 percent of their patients.

"Barriers to entry in clinical trials are a real problem. We have halay conversations daily about the need to make clinical research a standard healthcare option instead of something that physicians and cancer patients view as a 'Hail Mary' care approach.," said Brendan Early, vice president of clinical development for PRA Health Sciences. "This problem is multifactorial, with varying views. Today's forum was a very effective opportunity to look at the issue from all sides."

The objective of cancer research is to generate new knowledge that can be used to save lives and protect quality of life for patients with cancer. Clinical trials are a key step in that process and yet, only a small fraction of patients end up enrolling in a cancer clinical trial because of barriers that make participation difficult or even impossible. As a result, approximately 20 percent of cancer clinical trials fail due to insufficient patient enrollment.

The event included a panel discussion on understanding and addressing barriers. Panelists included with Shelton Earp, MD, director, UNC Lineberger Comprehensive Cancer Center, Michael Kastan, MD, PhD, executive director, Duke Cancer Institute, Karen Winkfield, MD, PhD, associate director for office of cancer health equity, Wake Forest Baptist Medical Comprehensive Cancer Center, Greg Licholai, MD, MBA, chief medical information officer, PRA Health Sciences, Jean Sellers, RN, MSN, administrative clinical director, UNC Lineberger, and The Honorable Gregory Murphy, MD, NC State Representative, District 9.

"We at ACS CAN hope today's research breakfast will raise awareness in our elected officials of the importance clinical trials play in our healthcare system," said Weason. "We encourage continued dialogue between the public and private sectors with the aim of implementing evidence-based initiatives to eliminate the barriers cancer patients face when seeking innovative clinical trial treatments."

This year, the American Cancer Society estimates that 55,130 people in North Carolina will be diagnosed with cancer and 20,380 will die from the disease.

© 2018 Targeted News Service

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Apr 22: Can Pharmacy Malpractice Be a Crime?
Apr 23: Management of Bipolar Disorder
Apr 24: Identifying, Targeting and Managing Chronic Renal Failure
Apr 25: COPD Update for Pharmacy Professionals
Apr 28: Pharmacy & the Opioid Crisis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement